Environmental Pollutants, Occupational Exposures, and Liver Disease

Abstract

Environmental pollutants significantly impact liver disease development, progression, and outcomes. This review examines the complex relationship between environmental exposures and liver pathology, from malignant conditions like hepatocellular carcinoma to steatotic and cholestatic liver diseases. Key environmental factors include air pollutants, volatile organic compounds, persistent organic pollutants, heavy metals, and per- and polyfluoroalkyl substances. These compounds can act through multiple mechanisms, including endocrine disruption, metabolic perturbation, oxidative stress, and direct hepatotoxicity. The impact of these exposures is often modified by factors such as sex, diet, and genetic predisposition. Recent research has revealed that even low-level exposures to certain chemicals can significantly affect liver health, particularly when combined with other risk factors. The emergence of exposomics as a research tool promises to enhance our understanding of how environmental factors influence liver disease. Importantly, exposure effects can vary by demographic and socioeconomic factors, highlighting environmental justice concerns. Implementation of this knowledge in clinical practice requires new diagnostic approaches, healthcare system adaptations, and increased awareness among medical professionals. In conclusion, this review provides a comprehensive examination of current evidence linking environmental exposures to liver disease and discusses implications for clinical practice and public health policy.

Keywords

environmental liver disease - occupational and environmental hepatology - toxicant-associated steatohepatitis - metabolism disrupting chemicals

Publikationsverlauf

Artikel online veröffentlicht:
21. März 2025

• References

• 1 Kopelman H, Robertson MH, Sanders PG, Ash I. The Epping jaundice. BMJ 1966; 1 (5486) 514-516
• 2 Solis-Herruzo JA, Vidal JV, Colina F, Castellano G, Muñoz-Yagüe MT, Morillas JD. Clinico-biochemical evolution and late hepatic lesions in the toxic oil syndrome. Gastroenterology 1987; 93 (03) 558-568
• 3 Benkerroum N. Retrospective and prospective look at aflatoxin research and development from a practical standpoint. Int J Environ Res Public Health 2019; 16 (19) 16
• 4 Carson RL. Silent Spring. New York Houghton Mifflin Company/Riverside Press; 1962
• 5 Beier JI, Arteel GE. Environmental exposure as a risk-modifying factor in liver diseases: knowns and unknowns. Acta Pharm Sin B 2021; 11 (12) 3768-3778
• 6 Ma N, Yip R, Lewis S. et al. Environmental exposures are important risk factors for advanced liver fibrosis in African American adults. JHEP Rep Innov Hepatol 2023; 5 (04) 100696
• 7 David N, Antignac JP, Roux M. et al. Associations between perfluoroalkyl substances and the severity of non-alcoholic fatty liver disease. Environ Int 2023; 180: 108235
• 8 Sen P, Qadri S, Luukkonen PK. et al. Exposure to environmental contaminants is associated with altered hepatic lipid metabolism in non-alcoholic fatty liver disease. J Hepatol 2022; 76 (02) 283-293
• 9 Samala N, Kulkarni M, Lele RS. et al. Associations between per- and polyfluoroalkyl substance exposures and metabolic dysfunction associated steatotic liver disease (MASLD) in adult National Health and Nutrition Examination Survey 2017 to 2018. Toxicol Sci 2024; 202 (01) 142-151
• 10 Cheng W, Li M, Zhang L. et al. Close association of PFASs exposure with hepatic fibrosis than steatosis: evidences from NHANES 2017-2018. Ann Med 2023; 55 (01) 2216943
• 11 Zhang Y, Zhang M, Jiang S. et al. Associations of perfluoroalkyl substances with metabolic-associated fatty liver disease and non-alcoholic fatty liver disease: NHANES 2017-2018. Cancer Causes Control 2024; 35 (09) 1271-1282
• 12 Zhang X, Zhao L, Ducatman A. et al. Association of per- and polyfluoroalkyl substance exposure with fatty liver disease risk in US adults. JHEP Rep Innov Hepatol 2023; 5 (05) 100694
• 13 Barouki R, Samson M, Blanc EB. et al. The exposome and liver disease—how environmental factors affect liver health. J Hepatol 2023; 79 (02) 492-505
• 14 Cheung AC, Walker DI, Juran BD, Miller GW, Lazaridis KN. Studying the exposome to understand the environmental determinants of complex liver diseases. Hepatology 2020; 71 (01) 352-362
• 15 Creech Jr JL, Johnson MN. Angiosarcoma of liver in the manufacture of polyvinyl chloride. J Occup Med 1974; 16 (03) 150-151
• 16 Guardiola JJ, Hardesty JE, Beier JI, Prough RA, McClain CJ, Cave MC. Plasma metabolomics analysis of polyvinyl chloride workers identifies altered processes and candidate biomarkers for hepatic hemangiosarcoma and its development. Int J Mol Sci 2021; 22 (10) 22
• 17 Wahlang B, Jin J, Beier JI. et al. Mechanisms of environmental contributions to fatty liver disease. Curr Environ Health Rep 2019; 6 (03) 80-94
• 18 VoPham T. Environmental risk factors for liver cancer and nonalcoholic fatty liver disease. Curr Epidemiol Rep 2019; 6 (01) 50-66
• 19 Costello E, Rock S, Stratakis N. et al. Exposure to per- and polyfluoroalkyl substances and markers of liver injury: a systematic review and meta-analysis. Environ Health Perspect 2022; 130 (04) 46001
• 20 Fritsche K, Ziková-Kloas A, Marx-Stoelting P, Braeuning A. Metabolism-disrupting chemicals affecting the liver: screening, testing, and molecular pathway identification. Int J Mol Sci 2023; 24 (03) 24
• 21 Erkekoglu P, Oral D, Chao MW, Kocer-Gumusel B. Hepatocellular carcinoma and possible chemical and biological causes: a review. J Environ Pathol Toxicol Oncol 2017; 36 (02) 171-190
• 22 Lang AL, Beier JI. Interaction of volatile organic compounds and underlying liver disease: a new paradigm for risk. Biol Chem 2018; 399 (11) 1237-1248
• 23 Angrish MM, Kaiser JP, McQueen CA, Chorley BN. Tipping the balance: hepatotoxicity and the 4 apical key events of hepatic steatosis. Toxicol Sci 2016; 150 (02) 261-268
• 24 Rusyn I, Arzuaga X, Cattley RC. et al. Key characteristics of human hepatotoxicants as a basis for identification and characterization of the causes of liver toxicity. Hepatology 2021; 74 (06) 3486-3496
• 25 Kanwal F, Neuschwander-Tetri BA, Loomba R, Rinella ME. Metabolic dysfunction-associated steatotic liver disease: update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver disease. Hepatology 2024; 79 (05) 1212-1219
• 26 European Association for the Study of the Liver. EASL clinical practice guideline: occupational liver diseases. J Hepatol 2019; 71(5): 1022-1037
• 27 Zheng S, Yang Y, Wen C. et al. Effects of environmental contaminants in water resources on nonalcoholic fatty liver disease. Environ Int 2021; 154: 106555
• 28 Dolce A, Della Torre S. Sex, nutrition, and NAFLD: relevance of environmental pollution. Nutrients 2023; 15 (10) 15
• 29 Oluyomi AO, Thrift AP, Olayode A, Symanski E, Roy H, El-Serag HB. Race/ethnicity and sex differences in the association between area-level arsenic exposure concentration and hepatocellular carcinoma (HCC) incidence rates in Texas. An ecological study. Environ Res 2024; 240 (Pt 2): 117538
• 30 Mooney BL. Incidence of nonalcoholic fatty liver disease rises quickly in U.S. military. In: Mooney BL. ed. 2019 Compendium of Federal Medicine. 2019: 33-35
• 31 Thrift AP, Nguyen TH, Pham C. et al. The prevalence and determinants of NAFLD and MAFLD and their severity in the VA primary care setting. Clin Gastroenterol Hepatol 2023; 21 (05) 1252-1260.e5
• 32 Heindel JJ, Blumberg B, Cave M. et al. Metabolism disrupting chemicals and metabolic disorders. Reprod Toxicol 2017; 68: 3-33
• 33 Lang AL, Chen L, Poff GD. et al. Vinyl chloride dysregulates metabolic homeostasis and enhances diet-induced liver injury in mice. Hepatol Commun 2018; 2 (03) 270-284
• 34 Barker DJ. The origins of the developmental origins theory. J Intern Med 2007; 261 (05) 412-417
• 35 Stratakis N, VConti D, Jin R. et al. Prenatal exposure to perfluoroalkyl substances associated with increased susceptibility to liver injury in children. Hepatology 2020; 72 (05) 1758-1770
• 36 Zoeller RT, Brown TR, Doan LL. et al. Endocrine-disrupting chemicals and public health protection: a statement of principles from The Endocrine Society. Endocrinology 2012; 153 (09) 4097-4110
• 37 Sargis RM, Simmons RA. Environmental neglect: endocrine disruptors as underappreciated but potentially modifiable diabetes risk factors. Diabetologia 2019; 62 (10) 1811-1822
• 38 Baillie-Hamilton PF. Chemical toxins: a hypothesis to explain the global obesity epidemic. J Altern Complement Med 2002; 8 (02) 185-192
• 39 Grün F, Blumberg B. Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling. Endocrinology 2006; 147 (06) S50-S55
• 40 Heindel JJ, Howard S, Agay-Shay K. et al. Obesity II: establishing causal links between chemical exposures and obesity. Biochem Pharmacol 2022; 199: 115015
• 41 Cave M, Falkner KC, Ray M. et al. Toxicant-associated steatohepatitis in vinyl chloride workers. Hepatology 2010; 51 (02) 474-481
• 42 Grant CW, Juran BD, Ali AH. et al. Environmental chemicals and endogenous metabolites in bile of USA and Norway patients with primary sclerosing cholangitis. Exposome 2023; 3 (01) osac011
• 43 Walker DI, Juran BD, Cheung AC. et al. High-resolution exposomics and metabolomics reveals specific associations in cholestatic liver diseases. Hepatol Commun 2022; 6 (05) 965-979
• 44 La Merrill MA, Vandenberg LN, Smith MT. et al. Consensus on the key characteristics of endocrine-disrupting chemicals as a basis for hazard identification. Nat Rev Endocrinol 2020; 16 (01) 45-57
• 45 La Merrill MA, Smith MT, McHale CM. et al. Consensus on the key characteristics of metabolism disruptors. Nat Rev Endocrinol 2024; . Epub ahead of print.
• 46 Smith MT, Guyton KZ, Gibbons CF. et al. Key characteristics of carcinogens as a basis for organizing data on mechanisms of carcinogenesis. Environ Health Perspect 2016; 124 (06) 713-721
• 47 Sagnelli E, Macera M, Russo A, Coppola N, Sagnelli C. Epidemiological and etiological variations in hepatocellular carcinoma. Infection 2020; 48 (01) 7-17
• 48 Jemal A, Ward EM, Johnson CJ. et al. Annual report to the nation on the status of cancer, 1975-2014, featuring survival. J Natl Cancer Inst 2017; 109 (09) 109
• 49 Block JB. Angiosarcoma of the liver following vinyl chloride exposure. JAMA 1974; 229 (01) 53-54
• 50 Mani H, Van Thiel DH. Mesenchymal tumors of the liver. Clin Liver Dis 2001; 5 (01) 219-257 , viii
• 51 Cohen SM, Storer RD, Criswell KA. et al. Hemangiosarcoma in rodents: mode-of-action evaluation and human relevance. Toxicol Sci 2009; 111 (01) 4-18
• 52 Yonemori K, Tsuta K, Ando M. et al. Contrasting prognostic implications of platelet-derived growth factor receptor-β and vascular endothelial growth factor receptor-2 in patients with angiosarcoma. Ann Surg Oncol 2011; 18 (10) 2841-2850
• 53 Liu S, He L, Bannister OB. et al. Western diet unmasks transient low-level vinyl chloride-induced tumorigenesis; potential role of the (epi-)transcriptome. Toxicol Appl Pharmacol 2023; 468: 116514
• 54 Falk H, Creech Jr JL, Heath Jr CW, Johnson MN, Key MM. Hepatic disease among workers at a vinyl chloride polymerization plant. JAMA 1974; 230 (01) 59-63
• 55 Spirtas R, Kaminski R. Angiosarcoma of the liver in vinyl chloride/polyvinyl chloride workers. 1977 update of the NIOSH register. J Occup Med 1978; 20 (06) 427-429
• 56 Lee FI, Harry DS. Angiosarcoma of the liver in a vinyl-chloride worker. Lancet 1974; 1 (7870) 1316-1318
• 57 Fedeli U, Girardi P, Gardiman G. et al. Mortality from liver angiosarcoma, hepatocellular carcinoma, and cirrhosis among vinyl chloride workers. Am J Ind Med 2019; 62 (01) 14-20
• 58 Cicalese L, Raun L, Shirafkan A. et al. An ecological study of the association between air pollution and hepatocellular carcinoma incidence in Texas. Liver Cancer 2017; 6 (04) 287-296
• 59 Mouchtaris Michailidis T, De Saeger S, Khoueiry R. et al. The interplay of dietary mycotoxins and oncogenic viruses toward human carcinogenesis: a scoping review. Crit Rev Food Sci Nutr 2024; 1-19. Epub ahead of print.
• 60 Cao W, Yu P, Yang K, Cao D. Aflatoxin B1: metabolism, toxicology, and its involvement in oxidative stress and cancer development. Toxicol Mech Methods 2022; 32 (06) 395-419
• 61 Liu Y, Chang CC, Marsh GM, Wu F. Population attributable risk of aflatoxin-related liver cancer: systematic review and meta-analysis. Eur J Cancer 2012; 48 (14) 2125-2136
• 62 Johnson NM, Qian G, Xu L. et al. Aflatoxin and PAH exposure biomarkers in a U.S. population with a high incidence of hepatocellular carcinoma. Sci Total Environ 2010; 408 (23) 6027-6031
• 63 Ross RK, Yuan JM, Yu MC. et al. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet 1992; 339 (8799) 943-946
• 64 Ming L, Thorgeirsson SS, Gail MH. et al. Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China. Hepatology 2002; 36 (05) 1214-1220
• 65 Sun Z, Chen T, Thorgeirsson SS. et al. Dramatic reduction of liver cancer incidence in young adults: 28 year follow-up of etiological interventions in an endemic area of China. Carcinogenesis 2013; 34 (08) 1800-1805
• 66 Kensler TW, Egner PA, Wang JB. et al. Chemoprevention of hepatocellular carcinoma in aflatoxin endemic areas. Gastroenterology 2004; 127 (5, Suppl 1): S310-S318
• 67 Ba Q, Li J, Huang C. et al. Effects of benzo[a]pyrene exposure on human hepatocellular carcinoma cell angiogenesis, metastasis, and NF-κB signaling. Environ Health Perspect 2015; 123 (03) 246-254
• 68 Bukowska B, Mokra K, Michałowicz J. Benzo[a]pyrene—environmental occurrence, human exposure, and mechanisms of toxicity. Int J Mol Sci 2022; 23 (11) 23
• 69 Su Y, Zhao B, Guo F. et al. Interaction of benzo[a]pyrene with other risk factors in hepatocellular carcinoma: a case-control study in Xiamen, China. Ann Epidemiol 2014; 24 (02) 98-103
• 70 Yang Y, Jin M, Meng Y. et al. Involvement and targeted intervention of benzo(a)pyrene-regulated apoptosis related proteome modification and muti-drug resistance in hepatocellular carcinoma. Cell Death Dis 2023; 14 (04) 265
• 71 Ge Y, Gu P, Wang W. et al. Benzo[a]pyrene stimulates miR-650 expression to promote the pathogenesis of fatty liver disease and hepatocellular carcinoma via SOCS3/JAK/STAT3 cascades. J Mol Cell Biol 2021; 13 (08) 556-564
• 72 Montano L, Pironti C, Pinto G. et al. Polychlorinated biphenyls (PCBs) in the environment: occupational and exposure events, effects on human health and fertility. Toxics 2022; 10 (07) 10
• 73 Ludewig G, Robertson LW. Polychlorinated biphenyls (PCBs) as initiating agents in hepatocellular carcinoma. Cancer Lett 2013; 334 (01) 46-55
• 74 Niehoff NM, Zabor EC, Satagopan J. et al. Prediagnostic serum polychlorinated biphenyl concentrations and primary liver cancer: a case-control study nested within two prospective cohorts. Environ Res 2020; 187: 109690
• 75 Saad-Hussein A, Beshir S, Taha MM. et al. Early prediction of liver carcinogenicity due to occupational exposure to pesticides. Mutat Res Genet Toxicol Environ Mutagen 2019; 838: 46-53
• 76 Harada T, Takeda M, Kojima S, Tomiyama N. Toxicity and carcinogenicity of dichlorodiphenyltrichloroethane (DDT). Toxicol Res 2016; 32 (01) 21-33
• 77 Kushida M, Sukata T, Uwagawa S. et al. Low dose DDT inhibition of hepatocarcinogenesis initiated by diethylnitrosamine in male rats: possible mechanisms. Toxicol Appl Pharmacol 2005; 208 (03) 285-294
• 78 Persson EC, Graubard BI, Evans AA. et al. Dichlorodiphenyltrichloroethane and risk of hepatocellular carcinoma. Int J Cancer 2012; 131 (09) 2078-2084
• 79 PFAS Explained. United States Environmental Protection Agency. Accessed at: https://www.epa.gov/pfas/pfas-explained
• 80 Glüge J, Scheringer M, Cousins IT. et al. An overview of the uses of per- and polyfluoroalkyl substances (PFAS). Environ Sci Process Impacts 2020; 22 (12) 2345-2373
• 81 Forsthuber M, Kaiser AM, Granitzer S. et al. Albumin is the major carrier protein for PFOS, PFOA, PFHxS, PFNA and PFDA in human plasma. Environ Int 2020; 137: 105324
• 82 Fischer FC, Ludtke S, Thackray C. et al. Binding of per- and polyfluoroalkyl substances (PFAS) to serum proteins: implications for toxicokinetics in humans. Environ Sci Technol 2024; 58 (02) 1055-1063
• 83 Lin PD, Cardenas A, Hauser R. et al. Temporal trends of concentrations of per- and polyfluoroalkyl substances among adults with overweight and obesity in the United States: results from the Diabetes Prevention Program and NHANES. Environ Int 2021; 157: 106789
• 84 Xing Y, Zhou Y, Zhang X. et al. The sources and bioaccumulation of per- and polyfluoroalkyl substances in animal-derived foods and the potential risk of dietary intake. Sci Total Environ 2023; 905: 167313
• 85 Goodrich JA, Walker D, Lin X. et al. Exposure to perfluoroalkyl substances and risk of hepatocellular carcinoma in a multiethnic cohort. JHEP Rep Innov Hepatol 2022; 4 (10) 100550
• 86 Liu J, Waalkes MP. Liver is a target of arsenic carcinogenesis. Toxicol Sci 2008; 105 (01) 24-32
• 87 Smith AH, Hopenhayn-Rich C, Bates MN. et al. Cancer risks from arsenic in drinking water. Environ Health Perspect 1992; 97: 259-267
• 88 Chiu HF, Ho SC, Wang LY, Wu TN, Yang CY. Does arsenic exposure increase the risk for liver cancer?. J Toxicol Environ Health A 2004; 67 (19) 1491-1500
• 89 Chan WK, Chuah KH, Rajaram RB, Lim LL, Ratnasingam J, Vethakkan SR. Metabolic dysfunction-associated steatotic liver disease (MASLD): a state-of-the-art review. J Obes Metab Syndr 2023; 32 (03) 197-213
• 90 Phoolchund AGS, Khakoo SI. MASLD and the development of HCC: pathogenesis and therapeutic challenges. Cancers (Basel) 2024; 16 (02) 16
• 91 Ya P, Xu H, Ma Y. et al. Liver injury induced in Balb/c mice by PM_2.5 exposure and its alleviation by compound essential oils. Biomed Pharmacother 2018; 105: 590-598
• 92 Yu H, Ma J, Chen D, Gao Y, Li G, An T. Associations between inhalation of typical volatile and semi-volatile organic compounds in e-waste dismantling workers with liver function damage. J Hazard Mater 2024; 464: 133004
• 93 Li FR, Liao J, Zhu B. et al. Long-term exposure to air pollution and incident non-alcoholic fatty liver disease and cirrhosis: a cohort study. Liver Int 2023; 43 (02) 299-307
• 94 Guo B, Guo Y, Nima Q. et al; China Multi-Ethnic Cohort (CMEC) collaborative group. Exposure to air pollution is associated with an increased risk of metabolic dysfunction-associated fatty liver disease. J Hepatol 2022; 76 (03) 518-525
• 95 Ji W, Cheng Y, Tang S. et al. Exposure to ambient air pollution and metabolic dysfunction-associated fatty liver disease: findings from over 2.7 million adults in Northwestern China. Ecotoxicol Environ Saf 2024; 272: 116109
• 96 Ye Z, Liu M, He P. et al. Various ambient air pollutants, residential green spaces, fibrosis 4 scores, genetic susceptibility, and risk of severe liver disease. Ecotoxicol Environ Saf 2023; 263: 115246
• 97 Liu M, Yang S, Ye Z. et al. Residential green and blue spaces with nonalcoholic fatty liver disease incidence: mediating effect of air pollutants. Ecotoxicol Environ Saf 2023; 264: 115436
• 98 Ran S, Zhang J, Tian F. et al. Association of metabolic signatures of air pollution with MASLD: observational and Mendelian randomization study. J Hepatol 2024; :S0168-8278(24)02573-X. Epub ahead of print.
• 99 Aimuzi R, Xie Z, Qu Y, Luo K, Jiang Y. Proteomic signatures of ambient air pollution and risk of non-alcoholic fatty liver disease: a prospective cohort study in the UK Biobank. Sci Total Environ 2024; 957: 177529
• 100 VoPham T, Kim NJ, Berry K, Mendoza JA, Kaufman JD, Ioannou GN. PM_2.5 air pollution exposure and nonalcoholic fatty liver disease in the Nationwide Inpatient Sample. Environ Res 2022; 213: 113611
• 101 Patterson WB, Holzhausen E, Chalifour B. et al. Exposure to ambient air pollutants, serum miRNA networks, lipid metabolism, and non-alcoholic fatty liver disease in young adults. Ecotoxicol Environ Saf 2023; 264: 115486
• 102 Schenker RB, Machle CJ, Allayee H. et al. Ambient air pollution exposure is associated with liver fat and stiffness in Latino youth with a more pronounced effect in those with PNPLA3 genotype and more advanced liver disease. Ecotoxicol Environ Saf 2024; 286: 117234
• 103 Schnegelberger RD, Lang AL, Arteel GE, Beier JI. Environmental toxicant-induced maladaptive mitochondrial changes: a potential unifying mechanism in fatty liver disease?. Acta Pharm Sin B 2021; 11 (12) 3756-3767
• 104 Case Studies on Safer Alternatives for Solvent Degreasing Applications. United States Environmental Protection Agency. Available at: https://www.epa.gov/p2/case-studies-safer-alternatives-solvent-degreasing-applications
• 105 Risk Management for Perchloroethylene (PCE). United States Environmental Protection Agency. Available at: https://www.epa.gov/assessing-and-managing-chemicals-under-tsca/risk-management-perchloroethylene-pce
• 106 Vipin Soni PS. Venu Shree & Varun Goel Effects of VOCs on Human Health. In, Air Pollution and Control. Springer; Singapore: 2018: 119-142
• 107 Sun W. The devastating health consequences of the Ohio derailment: a closer look at the effects of vinyl chloride spill. Int J Environ Res Public Health 2023; 20 (06) 20
• 108 Cakmak S, Cole C, Hebbern C, Andrade J, Dales R. Associations between blood volatile organic compounds, and changes in hematologic and biochemical profiles, in a population-based study. Environ Int 2020; 145: 106121
• 109 Wahlang B, Gao H, Rai SN. et al. Associations between residential volatile organic compound exposures and liver injury markers: the role of biological sex and race. Environ Res 2023; 221: 115228
• 110 Duan X, Chen Z, Liao J. et al. The association analysis between exposure to volatile organic compounds and fatty liver disease in US Adults. Dig Liver Dis 2025; 57 (02) 535-541
• 111 Ashraf MA. Persistent organic pollutants (POPs): a global issue, a global challenge. Environ Sci Pollut Res Int 2017; 24 (05) 4223-4227
• 112 Papalou O, Kandaraki EA, Papadakis G, Diamanti-Kandarakis E. Endocrine disrupting chemicals: an occult mediator of metabolic disease. Front Endocrinol (Lausanne) 2019; 10: 112
• 113 Guo W, Pan B, Sakkiah S. et al. Persistent organic pollutants in food: contamination sources, health effects and detection methods. Int J Environ Res Public Health 2019; 16 (22) 16
• 114 Wahlang B, Falkner KC, Clair HB. et al. Human receptor activation by aroclor 1260, a polychlorinated biphenyl mixture. Toxicol Sci 2014; 140 (02) 283-297
• 115 Masuda Y. Health status of Japanese and Taiwanese after exposure to contaminated rice oil. Environ Health Perspect 1985; 60: 321-325
• 116 Clair HB, Pinkston CM, Rai SN. et al. Liver disease in a residential cohort with elevated polychlorinated biphenyl exposures. Toxicol Sci 2018; 164 (01) 39-49
• 117 Kaifie A, Schettgen T, Gube M, Ziegler P, Kraus T, Esser A. Functional and structural liver abnormalities in former PCB exposed workers—analyses from the HELPcB cohort. J Toxicol Environ Health A 2019; 82 (01) 52-61
• 118 Maroni M, Colombi A, Arbosti G, Cantoni S, Foa V. Occupational exposure to polychlorinated biphenyls in electrical workers. II. Health effects. Br J Ind Med 1981; 38 (01) 55-60
• 119 Liu Q, Fan G, Bi J. et al. Associations of polychlorinated biphenyls and organochlorine pesticides with metabolic dysfunction-associated fatty liver disease among Chinese adults: effect modification by lifestyle. Environ Res 2024; 240 (Pt 2): 117507
• 120 Cave MC, Pinkston CM, Rai SN. et al. Circulating microRNAs, polychlorinated biphenyls, and environmental liver disease in the Anniston Community Health Survey. Environ Health Perspect 2022; 130 (01) 17003
• 121 Hjazi A, Hsu CY, Al-Attar WM. et al. The association of exposure to polychlorinated biphenyls with lipid profile and liver enzymes in umbilical cord blood samples. Chemosphere 2024; 350: 141096
• 122 Midya V, Colicino E, Conti DV. et al. Association of prenatal exposure to endocrine-disrupting chemicals with liver injury in children. JAMA Netw Open 2022; 5 (07) e2220176
• 123 Wahlang B. RISING STARS: sex differences in toxicant-associated fatty liver disease. J Endocrinol 2023; 258 (01) 258
• 124 Li MC, Chen PC, Tsai PC. et al. Mortality after exposure to polychlorinated biphenyls and polychlorinated dibenzofurans: a meta-analysis of two highly exposed cohorts. Int J Cancer 2015; 137 (06) 1427-1432
• 125 Bertazzi A, Pesatori AC, Consonni D, Tironi A, Landi MT, Zocchetti C. Cancer incidence in a population accidentally exposed to 2,3,7,8-tetrachlorodibenzo-para-dioxin. Epidemiology 1993; 4 (05) 398-406
• 126 Yi SW, Ohrr H. Agent Orange exposure and cancer incidence in Korean Vietnam veterans: a prospective cohort study. Cancer 2014; 120 (23) 3699-3706
• 127 Tsai PC, Ko YC, Huang W, Liu HS, Guo YL. Increased liver and lupus mortalities in 24-year follow-up of the Taiwanese people highly exposed to polychlorinated biphenyls and dibenzofurans. Sci Total Environ 2007; 374 (2-3): 216-222
• 128 VoPham T, Bertrand KA, Fisher JA, Ward MH, Laden F, Jones RR. Emissions of dioxins and dioxin-like compounds and incidence of hepatocellular carcinoma in the United States. Environ Res 2022; 204 (Pt D): 112386
• 129 Wahlang B, Hardesty JE, Jin J, Falkner KC, Cave MC. Polychlorinated biphenyls and nonalcoholic fatty liver disease. Curr Opin Toxicol 2019; 14: 21-28
• 130 Cave MC, Clair HB, Hardesty JE. et al. Nuclear receptors and nonalcoholic fatty liver disease. Biochim Biophys Acta 2016; 1859 (09) 1083-1099
• 131 Cano R, Pérez JL, Dávila LA. et al. Role of endocrine-disrupting chemicals in the pathogenesis of non-alcoholic fatty liver disease: a comprehensive review. Int J Mol Sci 2021; 22 (09) 22
• 132 Lee YM, Jacobs Jr DR, Lee DH. Persistent organic pollutants and type 2 diabetes: a critical review of review articles. Front Endocrinol (Lausanne) 2018; 9: 712
• 133 Wahlang B, Falkner KC, Gregory B. et al. Polychlorinated biphenyl 153 is a diet-dependent obesogen that worsens nonalcoholic fatty liver disease in male C57BL6/J mice. J Nutr Biochem 2013; 24 (09) 1587-1595
• 134 Wahlang B, Alexander II NC, Li X, Rouchka EC, Kirpich IA, Cave MC. Polychlorinated biphenyls altered gut microbiome in CAR and PXR knockout mice exhibiting toxicant-associated steatohepatitis. Toxicol Rep 2021; 8: 536-547
• 135 Klinge CM, Piell KM, Petri BJ. et al. Combined exposure to polychlorinated biphenyls and high-fat diet modifies the global epitranscriptomic landscape in mouse liver. Environ Epigenet 2021; 7 (01) dvab008
• 136 Petri BJ, Piell KM, Wahlang B. et al. Altered splicing factor and alternative splicing events in a mouse model of diet- and polychlorinated biphenyl-induced liver disease. Environ Toxicol Pharmacol 2023; 103: 104260
• 137 Wahlang B, Appana S, Falkner KC, McClain CJ, Brock G, Cave MC. Insecticide and metal exposures are associated with a surrogate biomarker for non-alcoholic fatty liver disease in the National Health and Nutrition Examination Survey 2003-2004. Environ Sci Pollut Res Int 2020; 27 (06) 6476-6487
• 138 Sang H, Lee KN, Jung CH, Han K, Koh EH. Association between organochlorine pesticides and nonalcoholic fatty liver disease in the National Health and Nutrition Examination Survey 2003-2004. Sci Rep 2022; 12 (01) 11590
• 139 Al-Eryani L, Wahlang B, Falkner KC. et al. Identification of environmental chemicals associated with the development of toxicant-associated fatty liver disease in rodents. Toxicol Pathol 2015; 43 (04) 482-497
• 140 Ji G, Xu C, Sun H. et al. Organochloride pesticides induced hepatic ABCG5/G8 expression and lipogenesis in Chinese patients with gallstone disease. Oncotarget 2016; 7 (23) 33689-33702
• 141 Liu Q, Wang Q, Xu C. et al. Organochloride pesticides impaired mitochondrial function in hepatocytes and aggravated disorders of fatty acid metabolism. Sci Rep 2017; 7: 46339
• 142 Rantakokko P, Männistö V, Airaksinen R. et al. Persistent organic pollutants and non-alcoholic fatty liver disease in morbidly obese patients: a cohort study. Environ Health 2015; 14: 79
• 143 Freire C, Koifman RJ, Koifman S. Hematological and hepatic alterations in Brazilian population heavily exposed to organochlorine pesticides. J Toxicol Environ Health A 2015; 78 (08) 534-548
• 144 National Toxicology Program. NTP toxicology and carcinogenesis studies of polybrominated biphenyls (CAS No. 67774-32-7)(Firemaster FF-1(R)) in F344/N rats and B6C3F1 mice (feed studies). Natl Toxicol Program Tech Rep Ser 1993; 398: 1-235
• 145 Kling P, Norman A, Andersson PL, Norrgren L, Förlin L. Gender-specific proteomic responses in zebrafish liver following exposure to a selected mixture of brominated flame retardants. Ecotoxicol Environ Saf 2008; 71 (02) 319-327
• 146 Shockley KR, Cora MC, Malarkey DE. et al. Comparative toxicity and liver transcriptomics of legacy and emerging brominated flame retardants following 5-day exposure in the rat. Toxicol Lett 2020; 332: 222-234
• 147 Chen X, Hu G, He B. et al. Effect of brominated flame retardants exposure on liver function and the risk of non-alcoholic fatty liver disease in the US population. Ecotoxicol Environ Saf 2024; 273: 116142
• 148 Zhao X, Chen T, Yang B. et al. Serum levels of novel brominated flame retardants (NBFRs) in residents of a major BFR-producing region: occurrence, impact factors and the relationship to thyroid and liver function. Ecotoxicol Environ Saf 2021; 208: 111467
• 149 Guo W, Lei L, Shi X. et al. Nonalcoholic fatty liver disease development in zebrafish upon exposure to bis(2-ethylhexyl)-2,3,4,5-tetrabromophthalate, a novel brominated flame retardant. Environ Sci Technol 2021; 55 (10) 6926-6935
• 150 Lim JJ, Goedken M, Jin Y, Gu H, Cui JY. Single-cell transcriptomics unveiled that early life BDE-99 exposure reprogrammed the gut-liver axis to promote a proinflammatory metabolic signature in male mice at late adulthood. Toxicol Sci 2024; 200 (01) 114-136
• 151 Sun Y, Wang Y, Liang B. et al. Hepatotoxicity of decabromodiphenyl ethane (DBDPE) and decabromodiphenyl ether (BDE-209) in 28-day exposed Sprague-Dawley rats. Sci Total Environ 2020; 705: 135783
• 152 Warner GR, Flaws JA. Bisphenol A and phthalates: how environmental chemicals are reshaping toxicology. Toxicol Sci 2018; 166 (02) 246-249
• 153 Zou J, Gu Q, Gu D. Association between phthalates exposure and non-alcoholic fatty liver disease under different diagnostic criteria: a cross-sectional study based on NHANES 2017 to 2018. Front Public Health 2024; 12: 1407976
• 154 National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Division on Earth and Life Studies; Board on Population Health and Public Health Practice; Board on Environmental Studies and Toxicology; Committee on the Guidance on PFAS Testing and Health Outcomes. The National Academies Collection: Reports funded by National Institutes of Health. In: Guidance on PFAS Exposure, Testing, and Clinical Follow-Up. Washington (DC): National Academies Press; 2022
• 155 Bassler J, Ducatman A, Elliott M. et al. Environmental perfluoroalkyl acid exposures are associated with liver disease characterized by apoptosis and altered serum adipocytokines. Environ Pollut 2019; 247: 1055-1063
• 156 Darrow LA, Groth AC, Winquist A, Shin HM, Bartell SM, Steenland K. Modeled perfluorooctanoic acid (PFOA) exposure and liver function in a mid-Ohio valley community. Environ Health Perspect 2016; 124 (08) 1227-1233
• 157 Mi X, Wu LY, Liu JJ. et al. The effects of Cl-PFESAs exposure on blood lipids—a community-based large population study in Guangzhou. Sci Total Environ 2022; 806 (Pt 2): 150634
• 158 Consonni D, Fustinoni S. Biochemical and haematological effects of serum PFOA, ADV and cC₆O₄ in workers of a chemical company producing fluoropolymers, Italy, 2013-2022. Int J Hyg Environ Health 2024; 262: 114440
• 159 Samala N, Kulkarni M, Lele RS. et al. Associations between per- and polyfluoroalkyl substance exposures and metabolic dysfunction associated steatotic liver disease (MASLD) in adult National Health and Nutrition Examination Survey 2017 to 2018. Toxicol Sci 2024; 202 (01) 142-151
• 160 Jin R, McConnell R, Catherine C. et al. Perfluoroalkyl substances and severity of nonalcoholic fatty liver in Children: An untargeted metabolomics approach. Environ Int 2020; 134: 105220
• 161 Frediani JK, Naioti EA, Vos MB, Figueroa J, Marsit CJ, Welsh JA. Arsenic exposure and risk of nonalcoholic fatty liver disease (NAFLD) among U.S. adolescents and adults: an association modified by race/ethnicity, NHANES 2005-2014. Environ Health 2018; 17 (01) 6
• 162 Park E, Kim J, Kim B, Park EY. Association between environmental exposure to cadmium and risk of suspected non-alcoholic fatty liver disease. Chemosphere 2021; 266: 128947
• 163 Moon MK, Lee I, Lee A. et al. Lead, mercury, and cadmium exposures are associated with obesity but not with diabetes mellitus: Korean National Environmental Health Survey (KoNEHS) 2015-2017. Environ Res 2022; 204 (Pt A): 111888
• 164 Chung SM, Moon JS, Yoon JS, Won KC, Lee HW. The sex-specific effects of blood lead, mercury, and cadmium levels on hepatic steatosis and fibrosis: Korean nationwide cross-sectional study. J Trace Elem Med Biol 2020; 62: 126601
• 165 Wan H, Wang Y, Zhang H. et al. Chronic lead exposure induces fatty liver disease associated with the variations of gut microbiota. Ecotoxicol Environ Saf 2022; 232: 113257
• 166 Yang Z, Wu J, Li X, Xie D, Wang Y, Yang T. Association between dietary iron intake and the prevalence of nonalcoholic fatty liver disease: a cross-sectional study. Medicine (Baltimore) 2019; 98 (43) e17613
• 167 Lan Y, Wu S, Wang Y. et al. Association between blood copper and nonalcoholic fatty liver disease according to sex. Clin Nutr 2021; 40 (04) 2045-2052
• 168 Sadighara P, Abedini AH, Irshad N, Ghazi-Khansari M, Esrafili A, Yousefi M. Association between non-alcoholic fatty liver disease and heavy metal exposure: a systematic review. Biol Trace Elem Res 2023; 201 (12) 5607-5615
• 169 Vethaak AD, Legler J. Microplastics and human health. Science 2021; 371 (6530) 672-674
• 170 Thompson RC, Olsen Y, Mitchell RP. et al. Lost at sea: where is all the plastic?. Science 2004; 304 (5672) 838
• 171 Cox KD, Covernton GA, Davies HL, Dower JF, Juanes F, Dudas SE. Human consumption of microplastics. Environ Sci Technol 2019; 53 (12) 7068-7074
• 172 Karbalaei S, Hanachi P, Walker TR, Cole M. Occurrence, sources, human health impacts and mitigation of microplastic pollution. Environ Sci Pollut Res Int 2018; 25 (36) 36046-36063
• 173 Zhao B, Rehati P, Yang Z, Cai Z, Guo C, Li Y. The potential toxicity of microplastics on human health. Sci Total Environ 2024; 912: 168946
• 174 Schwabl P, Köppel S, Königshofer P. et al. Detection of various microplastics in human stool: a prospective case series. Ann Intern Med 2019; 171 (07) 453-457
• 175 Leslie HA, van Velzen MJM, Brandsma SH, Vethaak AD, Garcia-Vallejo JJ, Lamoree MH. Discovery and quantification of plastic particle pollution in human blood. Environ Int 2022; 163: 107199
• 176 Saraluck A, Techarang T, Bunyapipat P, Boonchuwong K, Pullaput Y, Mordmuang A. Detection of microplastics in human breast milk and its association with changes in human milk bacterial microbiota. J Clin Med 2024; 13 (14) 13
• 177 Huang S, Huang X, Bi R. et al. Detection and analysis of microplastics in human sputum. Environ Sci Technol 2022; 56 (04) 2476-2486
• 178 Horvatits T, Tamminga M, Liu B. et al. Microplastics detected in cirrhotic liver tissue. EBioMedicine 2022; 82: 104147
• 179 Jenner LC, Rotchell JM, Bennett RT, Cowen M, Tentzeris V, Sadofsky LR. Detection of microplastics in human lung tissue using μFTIR spectroscopy. Sci Total Environ 2022; 831: 154907
• 180 Yang W, Li Y, Boraschi D. Association between microorganisms and microplastics: how does it change the host-pathogen interaction and subsequent immune response?. Int J Mol Sci 2023; 24 (04) 24
• 181 Rogers KL, Carreres-Calabuig JA, Gorokhova E, Posth NR. Micro-by-micro interactions: how microorganisms influence the fate of marine microplastics. Limnol Oceanogr Lett 2020; 5(1): 18-36
• 182 Prietl B, Meindl C, Roblegg E, Pieber TR, Lanzer G, Fröhlich E. Nano-sized and micro-sized polystyrene particles affect phagocyte function. Cell Biol Toxicol 2014; 30 (01) 1-16
• 183 Deng Y, Zhang Y, Lemos B, Ren H. Tissue accumulation of microplastics in mice and biomarker responses suggest widespread health risks of exposure. Sci Rep 2017; 7: 46687
• 184 Li B, Ding Y, Cheng X. et al. Polyethylene microplastics affect the distribution of gut microbiota and inflammation development in mice. Chemosphere 2020; 244: 125492
• 185 Jin Y, Lu L, Tu W, Luo T, Fu Z. Impacts of polystyrene microplastic on the gut barrier, microbiota and metabolism of mice. Sci Total Environ 2019; 649: 308-317
• 186 Zhao J, Adiele N, Gomes D. et al. Obesogenic polystyrene microplastic exposures disrupt the gut-liver-adipose axis. Toxicol Sci 2024; 198 (02) 210-220
• 187 Zhao J, Gomes D, Jin L. et al. Polystyrene bead ingestion promotes adiposity and cardiometabolic disease in mice. Ecotoxicol Environ Saf 2022; 232: 113239
• 188 Lu L, Wan Z, Luo T, Fu Z, Jin Y. Polystyrene microplastics induce gut microbiota dysbiosis and hepatic lipid metabolism disorder in mice. Sci Total Environ 2018; 631-632: 449-458
• 189 Heudorf U, Mersch-Sundermann V, Angerer J. Phthalates: toxicology and exposure. Int J Hyg Environ Health 2007; 210 (05) 623-634
• 190 Rochester JR. Bisphenol A and human health: a review of the literature. Reprod Toxicol 2013; 42: 132-155
• 191 Lioy PJ, Hauser R, Gennings C. et al. Assessment of phthalates/phthalate alternatives in children's toys and childcare articles: review of the report including conclusions and recommendation of the Chronic Hazard Advisory Panel of the Consumer Product Safety Commission. J Expo Sci Environ Epidemiol 2015; 25 (04) 343-353
• 192 Bornehag CG, Lundgren B, Weschler CJ, Sigsgaard T, Hagerhed-Engman L, Sundell J. Phthalates in indoor dust and their association with building characteristics. Environ Health Perspect 2005; 113 (10) 1399-1404
• 193 Wang W, Wu FY, Huang MJ, Kang Y, Cheung KC, Wong MH. Size fraction effect on phthalate esters accumulation, bioaccessibility and in vitro cytotoxicity of indoor/outdoor dust, and risk assessment of human exposure. J Hazard Mater 2013; 261: 753-762
• 194 Lv J, Sun S, Wu R. et al. Phthalate esters in dusts from different indoor and outdoor microenvironment and potential human health risk: a case study in Beijing. Environ Res 2025; 266: 120513
• 195 Loganathan SN, Kannan K. Occurrence of bisphenol A in indoor dust from two locations in the eastern United States and implications for human exposures. Arch Environ Contam Toxicol 2011; 61 (01) 68-73
• 196 Caban M, Stepnowski P. Determination of bisphenol A in size fractions of indoor dust from several microenvironments. Microchem J 2020; 153: 104392
• 197 Yu L, Yang M, Cheng M. et al. Associations between urinary phthalate metabolite concentrations and markers of liver injury in the US adult population. Environ Int 2021; 155: 106608
• 198 Sun J, Yang S, Zhang Y, Xiang W, Jiang X. Relationship between phthalates exposures and metabolic dysfunction-associated fatty liver disease in United States adults. PLoS One 2024; 19 (04) e0301097
• 199 Lang IA, Galloway TS, Scarlett A. et al. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 2008; 300 (11) 1303-1310
• 200 Muncke J. Exposure to endocrine disrupting compounds via the food chain: is packaging a relevant source?. Sci Total Environ 2009; 407 (16) 4549-4559
• 201 Benjamin S, Pradeep S, Josh MS, Kumar S, Masai E. A monograph on the remediation of hazardous phthalates. J Hazard Mater 2015; 298: 58-72
• 202 Ramadan M, Cooper B, Posnack NG. Bisphenols and phthalates: plastic chemical exposures can contribute to adverse cardiovascular health outcomes. Birth Defects Res 2020; 112 (17) 1362-1385
• 203 Dueñas-Moreno J, Mora A, Kumar M, Meng XZ, Mahlknecht J. Worldwide risk assessment of phthalates and bisphenol A in humans: the need for updating guidelines. Environ Int 2023; 181: 108294
• 204 Grindler NM, Vanderlinden L, Karthikraj R. et al. Exposure to phthalate, an endocrine disrupting chemical, alters the first trimester placental methylome and transcriptome in women. Sci Rep 2018; 8 (01) 6086
• 205 Rubin BS. Bisphenol A: an endocrine disruptor with widespread exposure and multiple effects. J Steroid Biochem Mol Biol 2011; 127 (1-2): 27-34
• 206 Eales J, Bethel A, Galloway T. et al. Human health impacts of exposure to phthalate plasticizers: an overview of reviews. Environ Int 2022; 158: 106903
• 207 Mondal T, Mondal S, Ghosh SK. et al. Phthalates—a family of plasticizers, their health risks, phytotoxic effects, and microbial bioaugmentation approaches. Environ Res 2022; 214 (Pt 3): 114059
• 208 Melzer D, Rice NE, Lewis C, Henley WE, Galloway TS. Association of urinary bisphenol a concentration with heart disease: evidence from NHANES 2003/06. PLoS One 2010; 5 (01) e8673
• 209 Shankar A, Teppala S. Relationship between urinary bisphenol A levels and diabetes mellitus. J Clin Endocrinol Metab 2011; 96 (12) 3822-3826
• 210 Hatch EE, Nelson JW, Qureshi MM. et al. Association of urinary phthalate metabolite concentrations with body mass index and waist circumference: a cross-sectional study of NHANES data, 1999-2002. Environ Health 2008; 7: 27
• 211 Legeay S, Faure S. Is bisphenol A an environmental obesogen?. Fundam Clin Pharmacol 2017; 31 (06) 594-609
• 212 Peng MQ, Karvonen-Gutierrez CA, Herman WH, Mukherjee B, Park SK. Phthalate exposure is associated with more rapid body fat gain in midlife women: The Study of Women's Health Across the Nation (SWAN) Multi-Pollutant Study. Environ Res 2023; 216 (Pt 3): 114685
• 213 Agency for Toxic Substances and Disease Registry ((ATSDR)). Toxicological profile for Polycyclic Aromatic Hydrocarbons (PAHs). Atlanta, GA: U.S. Department of Health and Human Services; Public Health Service; 1995
• 214 Xu C, Liu Q, Liang J. et al. Urinary biomarkers of polycyclic aromatic hydrocarbons and their associations with liver function in adolescents. Environ Pollut 2021; 278: 116842
• 215 Munir S, Azeem A, Sikandar Zaman M, Zia Ul Haq M. From field to table: ensuring food safety by reducing pesticide residues in food. Sci Total Environ 2024; 922: 171382
• 216 World Health Organization. Food and Agriculture Organization of the United Nations. Global Situation of Pesticide Management in Agriculture and Public Health: Report of a 2018 WHO-FAO Survey. Geneva: World Health Organization; 2019
• 217 Ren XM, Kuo Y, Blumberg B. Agrochemicals and obesity. Mol Cell Endocrinol 2020; 515: 110926
• 218 Hansen MRH, Gyawali B, Neupane D. et al. Pesticide exposure and diabetes mellitus in a semi-urban Nepali population: a cross-sectional study. Int Arch Occup Environ Health 2020; 93 (04) 513-524
• 219 Czajka M, Matysiak-Kucharek M, Jodłowska-Jędrych B. et al. Organophosphorus pesticides can influence the development of obesity and type 2 diabetes with concomitant metabolic changes. Environ Res 2019; 178: 108685
• 220 Petrovova E, Purzyc H, Mazensky D. et al. Morphometric alterations, steatosis, fibrosis and active caspase-3 detection in carbamate bendiocarb treated rabbit liver. Environ Toxicol 2015; 30 (02) 212-222
• 221 Yang D, Zhang X, Yue L. et al. Thiamethoxam induces nonalcoholic fatty liver disease in mice via methionine metabolism disturb via nicotinamide N-methyltransferase overexpression. Chemosphere 2021; 273: 129727
• 222 Séralini G-E, Clair E, Mesnage R. et al. Republished study: long-term toxicity of a Roundup herbicide and a Roundup-tolerant genetically modified maize. Environ Sci Eur 2014; 26 (01) 14
• 223 Thongprakaisang S, Thiantanawat A, Rangkadilok N, Suriyo T, Satayavivad J. Glyphosate induces human breast cancer cells growth via estrogen receptors. Food Chem Toxicol 2013; 59: 129-136
• 224 Mesnage R, Arno M, Costanzo M, Malatesta M, Séralini GE, Antoniou MN. Transcriptome profile analysis reflects rat liver and kidney damage following chronic ultra-low dose Roundup exposure. Environ Health 2015; 14: 70
• 225 Eskenazi B, Gunier RB, Rauch S. et al. Association of lifetime exposure to glyphosate and aminomethylphosphonic acid (AMPA) with liver inflammation and metabolic syndrome at young adulthood: findings from the CHAMACOS Study. Environ Health Perspect 2023; 131 (03) 37001
• 226 Kwon HC, Sohn H, Kim DH, Jeong CH, Kim DW, Han SG. Effects of flutriafol fungicide on the lipid accumulation in human liver cells and rat liver. Foods 2021; 10 (06) 10
• 227 Pirozzi AV, Stellavato A, La Gatta A, Lamberti M, Schiraldi C. Mancozeb, a fungicide routinely used in agriculture, worsens nonalcoholic fatty liver disease in the human HepG2 cell model. Toxicol Lett 2016; 249: 1-4
• 228 Xiao S, Cui J, Chen A. et al. Thyroid dysfunction induced by fungicide famoxadone exposure contributes to nonalcoholic fatty liver disease in male mice: in vivo, in vitro, and in silico studies. Environ Sci Technol 2023; 57 (40) 14881-14891
• 229 Arshad H, Mehmood MZ, Shah MH, Abbasi AM. Evaluation of heavy metals in cosmetic products and their health risk assessment. Saudi Pharm J 2020; 28 (07) 779-790
• 230 Balwierz R, Biernat P, Jasińska-Balwierz A. et al. Potential carcinogens in makeup cosmetics. Int J Environ Res Public Health 2023; 20 (06) 4780
• 231 Klančič V, Gobec M, Jakopin Ž. Environmental contamination status with common ingredients of household and personal care products exhibiting endocrine-disrupting potential. Environ Sci Pollut Res Int 2022; 29 (49) 73648-73674
• 232 Acir IH, Guenther K. Endocrine-disrupting metabolites of alkylphenol ethoxylates—a critical review of analytical methods, environmental occurrences, toxicity, and regulation. Sci Total Environ 2018; 635: 1530-1546
• 233 Casale T, Caciari T, Rosati MV. et al. Liver function in workers exposed of the cosmetics industry. Ann Ig 2013; 25 (06) 519-527
• 234 Alnuqaydan AM. The dark side of beauty: an in-depth analysis of the health hazards and toxicological impact of synthetic cosmetics and personal care products. Front Public Health 2024; 12: 1439027
• 235 Patel S. Fragrance compounds: the wolves in sheep's clothings. Med Hypotheses 2017; 102: 106-111
• 236 Schnell S, Bols NC, Barata C, Porte C. Single and combined toxicity of pharmaceuticals and personal care products (PPCPs) on the rainbow trout liver cell line RTL-W1. Aquat Toxicol 2009; 93 (04) 244-252
• 237 Schnell S, Martin-Skilton R, Fernandes D, Porte C. The interference of nitro- and polycyclic musks with endogenous and xenobiotic metabolizing enzymes in carp: an in vitro study. Environ Sci Technol 2009; 43 (24) 9458-9464
• 238 Politano VT, Lapczynski AA, Ritacco G, Api AM. Ninety-day toxicity study of alpha-iso-methylionone in rats. Int J Toxicol 2012; 31 (06) 595-601
• 239 Newcombe G, Chorus I, Falconer I, Lin TF. Cyanobacteria: impacts of climate change on occurrence, toxicity and water quality management. Water Res 2012; 46 (05) 1347-1348
• 240 Li T, Fan X, Cai M. et al. Advances in investigating microcystin-induced liver toxicity and underlying mechanisms. Sci Total Environ 2023; 905: 167167
• 241 Zhang F, Lee J, Liang S, Shum CK. Cyanobacteria blooms and non-alcoholic liver disease: evidence from a county level ecological study in the United States. Environ Health 2015; 14: 41
• 242 Stahre M, Roeber J, Kanny D, Brewer RD, Zhang X. Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States. Prev Chronic Dis 2014; 11: E109
• 243 King L, Aplin R, Gill C, Naimi T. A state-of-the-science review of alcoholic beverages and polycyclic aromatic hydrocarbons. Environ Health Perspect 2024; 132 (01) 16001
• 244 Lotti M. Do occupational exposures to vinyl chloride cause hepatocellular carcinoma and cirrhosis?. Liver Int 2017; 37 (05) 630-633
• 245 Yang J, Zhang L, Wang T. et al. Synergistic effects of combined treatment of 1,2-dichloroethane and high-dose ethanol on liver damage in mice and the related mechanisms. Food Chem Toxicol 2023; 176: 113812
• 246 Gripshover TC, Wahlang B, Head KZ. et al. Multiomics analysis of PCB126's effect on a mouse chronic-binge alcohol feeding model. Environ Health Perspect 2024; 132 (04) 47007
• 247 Gripshover TC, Wahlang B, Head KZ. et al. The environmental pollutant, polychlorinated biphenyl 126, alters liver function in a rodent model of alcohol-associated liver disease. Alcohol Clin Exp Res (Hoboken) 2023; 47 (01) 60-75
• 248 Mailloux RJ, Florian M, Chen Q. et al. Exposure to a northern contaminant mixture (NCM) alters hepatic energy and lipid metabolism exacerbating hepatic steatosis in obese JCR rats. PLoS One 2014; 9 (09) e106832
• 249 Ding S, Jiang J, Zhang G, Yu M, Zheng Y. Ambient particulate matter exposure plus chronic ethanol ingestion exacerbates hepatic fibrosis by triggering the mitochondrial ROS-ferroptosis signaling pathway in mice. Ecotoxicol Environ Saf 2023; 256: 114897
• 250 Petrescu AD, Venter J, Danilenko DD. et al. Exposure to Gulf war illness-related chemicals exacerbates alcohol-induced liver damage in rodents. Sci Rep 2024; 14 (01) 14981
• 251 Joshi-Barve S, Amancherla K, Patil M. et al. Acrolein, a ubiquitous pollutant and lipid hydroperoxide product, inhibits antiviral activity of interferon-alpha: relevance to hepatitis C. Free Radic Biol Med 2009; 47 (01) 47-54
• 252 Gershwin ME, Selmi C, Worman HJ. et al; USA PBC Epidemiology Group. Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology 2005; 42 (05) 1194-1202
• 253 Juran BD, Lazaridis KN. Environmental factors in primary biliary cirrhosis. Semin Liver Dis 2014; 34 (03) 265-272
• 254 Dyson JK, Blain A, Foster Shirley MD, Hudson M, Rushton S, Jeffreys Jones DE. Geo-epidemiology and environmental co-variate mapping of primary biliary cholangitis and primary sclerosing cholangitis. JHEP Rep Innov Hepatol 2020; 3 (01) 100202
• 255 Ala A, Stanca CM, Bu-Ghanim M. et al. Increased prevalence of primary biliary cirrhosis near Superfund toxic waste sites. Hepatology 2006; 43 (03) 525-531
• 256 Sargis RM, Heindel JJ, Padmanabhan V. Interventions to address environmental metabolism-disrupting chemicals: changing the narrative to empower action to restore metabolic health. Front Endocrinol (Lausanne) 2019; 10: 33
• 257 Guzelian PS. Therapeutic approaches for chlordecone poisoning in humans. J Toxicol Environ Health 1981; 8 (5-6): 757-766
• 258 Jandacek RJ, Heubi JE, Buckley DD. et al. Reduction of the body burden of PCBs and DDE by dietary intervention in a randomized trial. J Nutr Biochem 2014; 25 (04) 483-488
• 259 Mengozzi A, Carli F, Guiducci L. et al. SGLT2 inhibitors and thiazide enhance excretion of DEHP toxic metabolites in subjects with type 2 diabetes: a randomized clinical trial. Environ Res 2021; 192: 110316
• 260 Takasuga T, Senthilkumar K, Takemori H, Ohi E, Tsuji H, Nagayama J. Impact of FEBRA (fermented brown rice with Aspergillus oryzae) intake and concentrations of PCDDs, PCDFs and PCBs in blood of humans from Japan. Chemosphere 2004; 57 (10) 1409-1426
• 261 The National Academies of Sciences. Engineering, and Medicine. Guidance on PFAS Exposure, Testing, and Clinical Follow-Up. Washington, DC: The National Academies Press; 2022
• 262 Rinella ME, Lazarus JV, Ratziu V. et al; NAFLD Nomenclature Consensus Group. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Ann Hepatol 2024; 29 (01) 101133
• 263 Li R, Sun Q, Lam SM. et al. Sex-dependent effects of ambient PM_2.5 pollution on insulin sensitivity and hepatic lipid metabolism in mice. Part Fibre Toxicol 2020; 17 (01) 14
• 264 Deng P, Tang H, Zhu L. et al. Association of long-term ambient fine particulate matter (PM_2.5) and incident non-alcoholic fatty liver disease in Chinese adults. Environ Pollut 2023; 329: 121666
• 265 Markevych I, Wolf K, Hampel R. et al. Air pollution and liver enzymes. Epidemiology 2013; 24 (06) 934-935
• 266 Fedeli U, Girardi P, Mastrangelo G. Occupational exposure to vinyl chloride and liver diseases. World J Gastroenterol 2019; 25 (33) 4885-4891
• 267 Luo J, Watson WH, Gripshover TC, Qaissi Z, Wahlang B. Sex-specific effects of acute chlordane exposure in the context of steatotic liver disease, energy metabolism and endocrine disruption. Food Chem Toxicol 2023; 180: 114024
• 268 Zhang Y, Lu M, Zhou P, Wang C, Zhang Q, Zhao M. Multilevel evaluations of potential liver injury of bifenthrin. Pestic Biochem Physiol 2015; 122: 29-37
• 269 Averina M, Huber S, Almås B. et al. Early menarche and other endocrine disrupting effects of per- and polyfluoroalkyl substances (PFAS) in adolescents from Northern Norway. The Fit Futures study. Environ Res 2024; 242: 117703
• 270 Men H, Young JL, Zhou W. et al. Early-life exposure to low-dose cadmium accelerates diethylnitrosamine and diet-induced liver cancer. Oxid Med Cell Longev 2021; 2021: 1427787
• 271 Tinkov AA, Aschner M, Santamaria A. et al. Dissecting the role of cadmium, lead, arsenic, and mercury in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Environ Res 2023; 238 (Pt 1): 117134
• 272 Coradduzza D, Congiargiu A, Azara E. et al. Heavy metals in biological samples of cancer patients: a systematic literature review. Biometals 2024; 37 (04) 803-817
• 273 Hyder O, Chung M, Cosgrove D. et al. Cadmium exposure and liver disease among US adults. J Gastrointest Surg 2013; 17 (07) 1265-1273
• 274 Hardesty JE, Al-Eryani L, Wahlang B. et al. Epidermal growth factor receptor signaling disruption by endocrine and metabolic disrupting chemicals. Toxicol Sci 2018; 162 (02) 622-634